Abstract
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. Genetic and epidemiologic studies point to a relevant role of adaptive T-cell response interactions with environmental factors such as smoking in the immunopathogenesis of the disease. These interactions result in a specific systemic autoantibody response that seems to contribute to the synovial inflammatory process. The reasons for specific localization of the autoimmune proinflammatory process to synovial tissue remain poorly known, but relevant local effector mechanisms have been recently unveiled and successfully targeted by new specific therapies. A relevant role for cytokine networks, where TNF-α displays a pivotal role, has been confirmed. The local pathology is hallmarked by immune cell accumulation and expansion of resident stromal and vascular cells. Crosstalk between these elements generates an aggressive environment that leads to cartilage and bone destruction.
RA provides represents a model for systemic T-cell mediated systemic autoimmunity leading to local cellular and autoantibody mediated chronic inflammation. Whereas targeting of these elements with specific antagonists may interfere with the disease process, reestablishing tolerance and preventing further synovial inflammation has not been achieved.
Keywords: Rheumatoid Arthritis, Synovial pathology, Cytokines, T-cells, B-cells, Autoantibodies.
Current Topics in Medicinal Chemistry
Title:Immunopathology of Rheumatoid Arthritis
Volume: 13 Issue: 6
Author(s): Jose L. Pablos and Juan D. Canete
Affiliation:
Keywords: Rheumatoid Arthritis, Synovial pathology, Cytokines, T-cells, B-cells, Autoantibodies.
Abstract: Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. Genetic and epidemiologic studies point to a relevant role of adaptive T-cell response interactions with environmental factors such as smoking in the immunopathogenesis of the disease. These interactions result in a specific systemic autoantibody response that seems to contribute to the synovial inflammatory process. The reasons for specific localization of the autoimmune proinflammatory process to synovial tissue remain poorly known, but relevant local effector mechanisms have been recently unveiled and successfully targeted by new specific therapies. A relevant role for cytokine networks, where TNF-α displays a pivotal role, has been confirmed. The local pathology is hallmarked by immune cell accumulation and expansion of resident stromal and vascular cells. Crosstalk between these elements generates an aggressive environment that leads to cartilage and bone destruction.
RA provides represents a model for systemic T-cell mediated systemic autoimmunity leading to local cellular and autoantibody mediated chronic inflammation. Whereas targeting of these elements with specific antagonists may interfere with the disease process, reestablishing tolerance and preventing further synovial inflammation has not been achieved.
Export Options
About this article
Cite this article as:
L. Pablos Jose and Canete Juan D., Immunopathology of Rheumatoid Arthritis, Current Topics in Medicinal Chemistry 2013; 13 (6) . https://dx.doi.org/10.2174/1568026611313060003
| DOI https://dx.doi.org/10.2174/1568026611313060003 |
Print ISSN 1568-0266 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Artificial intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease
The title "Artificial Intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease" emphasizes the use of Artificial intelligence (AI) and advanced in silico methods to address Alzheimer's disease (AD), a neurodegenerative condition that currently has few effective treatments. AI and insilico methods, including molecular modeling, simulations, are ...read more
Big Data in Biomedicine: Integrating Bioinformatics and Clinical Databases
The rapid advancement of big data technologies is transforming biomedicine by integrating bioinformatics and clinical databases to drive precision medicine and innovative healthcare solutions. This thematic issue explores the intersection of computational biology, machine learning, and biomedical informatics, highlighting how large-scale data analysis enhances disease diagnosis, biomarker discovery, and personalized ...read more
Enzyme-Targeted Drug Discovery: Emerging Targets, Strategic Approaches, and Evaluation Frameworks
Enzyme-targeted drug discovery represents one of the most relevant strategies in pharmaceutical development, owing to the high specificity, selectivity, and central role of enzymes in the regulation of biological processes. This proposed issue aims to compile key information on the current landscape of enzyme-targeted drug discovery, with emphasis on the ...read more
From Code to Cure: The Evolving Landscape of Computer-Aided Drug Discovery and AI-Driven Design
Advancements in computational science and high-performance computing have made computer-aided drug design (CADD) a fundamental approach in modern drug discovery. CADD enables precise molecular-level analysis of target binding sites and interaction mechanisms, expediting the identification and refinement of drug candidates. It comprises structure-based drug design (SBDD), enhanced by crystallography and ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology Recent Advances in Immune Modulation
Current Gene Therapy Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening
Mini-Reviews in Medicinal Chemistry Gist Representations and Communication of Risks about HIV-AIDS: A Fuzzy-Trace Theory Approach
Current HIV Research The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Current Drug Targets Prostanoid Receptors as Possible Targets for Anti-Allergic Drugs: Recent Advances in Prostanoids on Allergy and Immunology
Current Drug Targets Segmentation of Ocular Thermogram Using Level-set Algorithm for Analysis of Contralateral Portions in Healthy Eyes
Current Medical Imaging Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry Chemical Constituents and Bioactivities of Gorgonian Corals
Current Organic Chemistry Musculoskeletal US: Taking the Management of Psoriatic Arthritis to a New Horizon
Current Rheumatology Reviews Targeting C5a: Recent Advances in Drug Discovery
Current Medicinal Chemistry Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Peripheral Benzodiazepine Receptor Ligands and their Anti-Inflammatory Effects
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies
Medicinal Chemistry Emerging Phytochemical Formulations for Management of Rheumatoid Arthritis: A Review
Current Drug Delivery Preparation of 2-(4-{[4-(Quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl) Propionic Acid (VUFB 20615) and 2-Methyl-2-(4-{[4-(quinolin-2- ylmethoxy)Phenyl]sulfanyl}phenyl)Propionic Acid (VUFB 20623) as Potential Antileukotrienic Agents
Current Organic Chemistry Subject Index to Volume 2
Current Drug Targets - Inflammation & Allergy Bioactive Compounds of <i>Polygonatum sibiricum</i> - Therapeutic Effect and Biological Activity
Endocrine, Metabolic & Immune Disorders - Drug Targets Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill
Current Medicinal Chemistry





